Spero Announces Appointment of Scott Jackson to Its Board of Directors
April 16, 2020 at 09:30 am EDT
Spero Therapeutics, Inc. announced the appointment of Scott Jackson to its Board of Directors, effective as of today. Mr. Jackson has more than thirty years of corporate leadership experience within the pharmaceutical and biotechnology industry, most recently serving as the Chief Executive Officer and a member of the Board of Directors of Celator Pharmaceuticals, Inc. until it was acquired by Jazz Pharmaceuticals plc.